Latest News

Date Posted: 08 November 2011
Dr Tim Leunig explores the ramifications of Pfizer shutting its operations in Kent, and examines the choices on hand for locals.   Read More ...

Date Posted: 19 October 2011
As part of Unilabs York Bioanalytical Solutions’ (Unilabs YBS) commitment to providing an unparalleled service to its clients, YBS is pleased to announce the opening of a new facility on the Discovery Park in Sandwich Kent. The new facility will offer discovery bioanalysis and biotransformation services.    Read More ...

Date Posted: 28 June 2011
Unilabs has been selected by Biogen Idec to provide a companion diagnostic anti-JCV antibody assay test, called STRATIFY-JCV. The test is a highly sensitive two-step ELISA assay used to detect anti-JCV antibodies. The presence of anti-JCV antibodies is one in a three-factor risk stratification algorithm, along with prior immunosuppressant use and treatment duration, used to calculate the risk of TYSABRI-treated patients developing progressive multifocal leukoencephalopathy (PML).   Read More ...

Date Posted: 19 April 2011
Unilabs York Bioanalytical Solutions (YBS) has a history of employing cutting edge technology to maintain its place as Europe’s premier, independent bioanalytical facility.   Read More ...

Date Posted: 01 December 2010
Method Development specialist brings more than 20 years of experience within the drug development industry to ensure that Unilabs YBS is positioned as one of the most significant independent suppliers of bioanalysis for NCEs and NBEs as well as biomarkers and sample management in Europe.   Read More ...

Date Posted: 09 November 2010
- Renowned specialist brings more than 20 years of drug development experience to develop and promote new businesses at YBS in Copenhagen and York.   Read More ...

Date Posted: 02 November 2010
YBS, one of the most significant independent supplier of bioanalysis for NCEs and NBEs as well as biomarkers and sample management in Europe, has launched a new updated website - www.yorkbio.com. The new website provides an improved information resource about YBS' services within the drug development industry.   Read More ...

Date Posted: 26 October 2010
This renowned immunoassay specialist brings more than 25 years of drug development experience to develop and promote new technology at YBS in Copenhagen.   Read More ...

Date Posted: 27 September 2010
In order to develop its positition as a leading Independent Bioanalytical CRO in Europe, Unilabs Drug Development Services changes brand to York Bioanalytical Solutions, YBS, as of today.   Read More ...

Date Posted: 20 April 2010
In order to strengthen their position as market-leaders in bioanalytical support for drug development studies, Unilabs and Biomonitor announced today the cooperation on measuring anti-drug antibodies (ADA) to biologicals.   Read More ...